Safety Meta-Analysis Trumped By Long, Large Trial At Spiriva Advisory Panel

A clinical trial trumps a meta-analysis for assessing drug safety, at least when it's large and well-done - that was the message from FDA's Pulmonary-Allergy Drugs Advisory Committee during its review of an additional indication for Boehringer Ingelheim's Spiriva HandiHaler Nov. 19